意大利放射治疗与临床肿瘤学会(AIRO)共识:新发转移性激素敏感性前列腺癌(mHSPC)的管理及放射治疗的作用
意大利放射治疗与临床肿瘤学会(AIRO)泌尿生殖组通过估计-讨论-估计方法制定共识,针对新发转移性激素敏感性前列腺癌(mHSPC)原发灶及转移灶的放射治疗指征形成7个结论性条目和12条声明,旨在帮助临床医生日常实践中的前列腺癌管理。
要点
- 共识针对新发mHSPC原发灶和转移灶的放疗指征形成7个条目、12条声明。
- 采用估计-讨论-估计(estimate-talk-estimate)方法由专家组制定。
- 共识旨在辅助临床医生在日常实践中管理前列腺癌。
核心结论
- 该共识可能有助于临床医生在日常临床实践中管理前列腺癌。
研究设计与样本
- 意大利放射治疗与临床肿瘤学会(AIRO)泌尿生殖组专家组采用估计-讨论-估计方法制定共识。
主要发现
- 共识别7个结论性条目,针对新发mHSPC原发灶和转移灶的放射治疗形成12条声明。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate cancer treatments paradigms are in continuous evolution, especially in the metastatic setting. In this context, the Genito-Urinary Group of Italian Association of Radiotherapy and Clinical Oncology aimed to create a consensus on radiation therapy indication in de novo metastatic hormone-sensitive prostate cancer both on primary tumor and metastatic sites. METHODS: A panel of experts, involved in clinical management of prostate cancer, through the estimate-talk-estimate method, developed a list of items and correspondent statements on the identified topic. RESULTS: Seven conclusive items were identified with 12 statements about the chosen topic, radiation therapy in metastatic hormone-sensitive prostate cancer on primary tumor and metastatic sites. CONCLUSIONS: This consensus might help clinicians in prostate cancer managing in daily clinical practice.
引用
- Lancia A, Alitto AR, Pappagallo G, et al. Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Pract Radiat Oncol. 2024. PMID: 39490734. doi:10.1016/j.prro.2024.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。